Once-daily (dinnertime) NovoMix® 30 with metformin
{"Image DocumentName": "Once-daily (dinnertime) NovoMix\u00ae 30 with metformin", "Image ImageDescription": "Metformin + NovoMix\u00ae 30 od (n = 45) Run-in period \u2013 metformin (up to 2550 mg/day) Metformin + human insulin NPH od (n = 47) Follow-up. Metformin + BHI 30 od (n = 46) BIAsp Aim To compare three combinations of metformin with 1) NovoMix 30, within 10 minutes before the meal, 2) biphasic human insulin, 30 minutes before the meal, 3) human insulin NPH, at bedtime. Trial design The study was an open-label, randomised, parallel-group, multicentre, 3-arm trial with a 4 week run-in period and 2 week follow-up. The trial involved 138 type 2 patients who were receiving either metformin or metformin in combination with sulphonylurea or repaglinide for at least 3 months. Both men and women enrolled, and had a BMI of < 40 kg/m2 and HbA1c of > 7.5%. Eligible patients: FPG \uf0b3 126 mg/dl. \u2013 Weeks. Kilo C et al. J Diabetes Complications 2003;17(6):", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}